Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating symptom-driven maintenance and reliever treatment to prevent exacerbations in COPD is ongoing or pending status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medical Center Groningen | Conditions: COPD | Phase 3 | Status: UNKNOWN